Sofia Zanotti
Overview
Explore the profile of Sofia Zanotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasqualetti F, Barberis A, Zanotti S, Montemurro N, De Salvo G, Soffietti R, et al.
Crit Rev Oncol Hematol
. 2023 Jul;
188:104065.
PMID: 37392899
Despite advances in the therapy of Central Nervous System (CNS) malignancies, treatment of glioblastoma (GB) poses significant challenges due to GB resistance and high recurrence rates following post-operative radio-chemotherapy. The...
2.
Pasqualetti F, Zanotti S
Br J Cancer
. 2023 Feb;
129(6):895-896.
PMID: 36792723
Recently, Liau et al. reported the results of Phase 3 clinical trial testing DCVax-L vaccines on patients with glioblastoma. Despite the promising and significant results obtained, the study design and...
3.
Zanotti S, Boot G, Coto-Llerena M, Gallon J, Hess G, Soysal S, et al.
Front Med (Lausanne)
. 2022 Jul;
9:888850.
PMID: 35814741
Hepatocellular carcinoma (HCC) typically develops from a background of cirrhosis resulting from chronic inflammation. This inflammation is frequently associated with chronic liver diseases (CLD). The advent of next generation sequencing...
4.
Zanotti S, Decaesteker B, Vanhauwaert S, De Wilde B, De Vos W, Speleman F
Br J Cancer
. 2022 Feb;
126(11):1529-1538.
PMID: 35197583
Neuroblastoma is a tumour that arises from the sympathoadrenal lineage occurring predominantly in children younger than five years. About half of the patients are diagnosed with high-risk tumours and undergo...
5.
Pasqualetti F, Sainato A, Morganti R, Laliscia C, Vasile E, Gonnelli A, et al.
Anticancer Res
. 2021 Oct;
41(10):4697-4704.
PMID: 34593417
Aim: Pancreatic adenocarcinoma is a life-threatening disease with a rising frequency and the fourth leading cause of cancer death. This review aimed to assess the impact of postoperative radiotherapy through...
6.
Zanotti S, Vanhauwaert S, Van Neste C, Olexiouk V, Van Laere J, Verschuuren M, et al.
Sci Rep
. 2021 Jul;
11(1):14454.
PMID: 34262099
MYCN is an oncogenic driver in neural crest-derived neuroblastoma and medulloblastoma. To better understand the early effects of MYCN activation in a neural-crest lineage context, we profiled the transcriptome of...